TY  - CONF

T1  - Cost-effectiveness of bosentan versus epoprostenol and no active treatment when added to palliative care for UK patients with pulmonary arterial hypertension of WHO functional class III

JO  - EUROPEAN HEART JOURNAL

PY  - 2008/09/01

AU  - Stevenson MD

AU  - Macdonald FC

AU  - Langley J

AU  - Akehurst RL

ED  - 

VL  - 29

SP  - 859

EP  - 859

Y2  - 2024/10/18

ER  -